Etripamil

Overview

Etripamil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3707312).

API suppliers (1)

Suppliers of Etripamil backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Dipharma Francis SrlItaly1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Etripamil expires 15 Jul 2042 and exclusivity 12 Dec 2030. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

methyl 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-methylamino]ethyl]benzoate

Canonical SMILES

CC(C)[C@](CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC

InChIKey

VAZNEHLGJGSQEL-MHZLTWQESA-N